ADRIAN UNGER: Open Payments
NPI 1396210514 · TAHLEQUAH, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 6 payments from 4 companies in 2025. Trend: 2023 $145 · 2024 $360 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $79 |
| Astellas Pharma US Inc | 1 | $30 |
| Averitas Pharma Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $16 |
Products named: INGREZZA, Veozah, QUTENZA, MOUNJARO.
Industry payments across OK — which companies pay providers there.
